Company Filing History:
Years Active: 2023-2025
Title: Anton Jan Van Zonneveld: Innovator in Polyomavirus Research
Introduction
Anton Jan Van Zonneveld is a notable inventor based in Soest, Netherlands. He has made significant contributions to the field of virology, particularly in the modulation of polyomavirus replication. His innovative work has led to the development of a patent that addresses critical aspects of viral behavior.
Latest Patents
Anton Jan Van Zonneveld holds a patent titled "Inhibition of polyomavirus replication." This invention relates to antisense molecules and methods for modulating the splicing of polyomavirus T antigen pre-mRNA. The patent describes an antisense oligonucleotide that is 12 to 30 nucleobases in length, preferably between 17 and 20 nucleobases. This oligonucleotide comprises a sequence that is the reverse complement of a contiguous stretch of at least 12 nucleobases of polyomavirus T-antigen pre-mRNA. The invention aims to modulate the splicing of T-antigen pre-mRNA in a cell, providing a potential therapeutic avenue for addressing polyomavirus-related diseases.
Career Highlights
Anton Jan Van Zonneveld is affiliated with Academisch Ziekenhuis Leiden, also known as LUMC. His work at this esteemed institution has allowed him to focus on groundbreaking research in the field of virology. His dedication to understanding viral mechanisms has positioned him as a key figure in the scientific community.
Collaborations
Throughout his career, Anton has collaborated with esteemed colleagues, including Eric Peter Van Der Veer and Jurriën Prins. These collaborations have fostered a rich environment for innovation and have contributed to the advancement of research in their shared field.
Conclusion
Anton Jan Van Zonneveld's contributions to the understanding of polyomavirus replication through his innovative patent highlight his role as a significant inventor in virology. His work continues to inspire further research and development in this critical area of health science.